In an update on the status of the FDA Center for Devices and Radiological Health (CDRH) as it has emerged from the COVID-19 public health emergency, the center’s leadership reported a return to normalcy in the handling of premarket submissions, as well as high levels of innovation in the development of medical devices. “Besides the lessons learned responding to an unprecedent... Read More